Joint Formulary & PAD

Colestyramine - Bile acid malabsorption

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Sachets (powder)
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Preferred
These are the recommended 1st line treatment option (ordinary sachets, with sugar)
 

Status 2

Blue
Formulations :
  • Sachets (SUGAR FREE powder)
Associated Icons :
BNF SPC
R
Un
Restrictions / Comments :
Important
3rd line colestyramine (sugar free) – for diabetic patients who request a sugar free formulation. Most costly preparation. The ordinary powder sachets are 1st line.

PAD Profile

ChemicalSubstance :
Colestyramine
Indication :
Bile acid malabsorption
Group Name :
Keywords :
BAM, bile salt absorption, bile acid sequestrants, bile acid diarrhoea
Brand Names Include :
Questran, Questran Light
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Colestyramine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Bile acid malabsorption.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the following traffic light statuses and place in therapy for treatments used in Bile Acid Malabsorption (BAM)

 BLUE traffic light status (on recommendation by a specialist)

·         1st line colestyramine (with sugar)

·         2nd line colesevelam

·         3rd colestyramine (sugar free) – for diabetic patients who request a sugar free formulation. Most costly preparation

A patient information leaflet is available - see Documentation